In T-ALL, over 40% of patients with JAK3 GOF mutations also possessed PHF6 LOF mutations, with this cohort showing reduced survival, while PHF6 inactivation in mice accelerated cell transformation mediated by JAK3 M511I, inducing an aggressive form of leukemia [63]. This evidence concerns the gene JAK3 and leukemia.